A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin
Clinical trial NCT01713530 · COMPLETED
Trial details
- NCT number
- NCT01713530
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-21
- Primary completion
- 2014-01-09
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.